HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nora Zulehner Selected Research

Hypersensitivity (Allergy)

1/2014The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nora Zulehner Research Topics

Disease

7Neoplasms (Cancer)
11/2012 - 01/2011
6Breast Neoplasms (Breast Cancer)
11/2012 - 01/2011
1Hypersensitivity (Allergy)
01/2014
1Seasonal Allergic Rhinitis (Hay Fever)
01/2014
1Genomic Instability
11/2012
1Ovarian Neoplasms (Ovarian Cancer)
11/2012
1Adenocarcinoma of Lung
01/2011
1Lung Neoplasms (Lung Cancer)
01/2011

Drug/Important Bio-Agent (IBA)

5Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2011 - 01/2011
5RoscovitineIBA
04/2011 - 01/2011
3Proteins (Proteins, Gene)FDA Link
01/2014 - 02/2011
3DNA (Deoxyribonucleic Acid)IBA
11/2012 - 01/2011
3Estrogens (Estrogen)FDA Link
04/2011 - 01/2011
3TamoxifenFDA LinkGeneric
03/2011 - 01/2011
2Hormones (Hormone)IBA
03/2011 - 01/2011
2SteroidsIBA
03/2011 - 01/2011
1AllergensIBA
01/2014
1A-factor (Streptomyces)IBA
01/2014
1C 1305IBA
11/2012
1Type I DNA Topoisomerases (Topoisomerase I)IBA
11/2012
1Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2012
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2012
1Estrogen ReceptorsIBA
03/2011
1Selective Estrogen Receptor Modulators (SERM)IBA
03/2011
1Cyclin-Dependent Kinase Inhibitor p16IBA
02/2011
1CyclinsIBA
02/2011
1Caspase 3 (Caspase-3)IBA
01/2011
1Adenosine Triphosphate (ATP)IBA
01/2011
1Cisplatin (Platino)FDA LinkGeneric
01/2011
1Estrogen Receptor Modulators (Antiestrogen)IBA
01/2011

Therapy/Procedure

1Therapeutics
01/2011